BackFresh Tracks Therapeutics Overview

Fresh Tracks Therapeutics Inventory

Latest inventory for FRTX: $550K.

Get informed when a big investor buys or sells

+ Follow
Inventory
$545000.00

Peer average / median

Loading

Fresh Tracks Therapeutics Inventory History

Loading

Fresh Tracks Therapeutics vs. peers: Inventory Comparison

Loading

Fresh Tracks Therapeutics Inventory Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Fresh Tracks Therapeutics (FRTX) FAQ

As of the most recent data (December 2023), FRTX shows a inventory of $550K. In the prior-year period, the figure was $0. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, FRTX's inventory is now $550K (was $0). Pairing that YoY change with peer averages gives a clearer picture of whether Fresh Tracks Therapeutics is outperforming or lagging.

Tracking FRTX's inventory over time shows whether Fresh Tracks Therapeutics is scaling, shrinking, or reshaping that part of the business. The current reading is $550K In the prior-year period, the figure was $0. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this inventory page, Stockcircle has Fresh Tracks Therapeutics's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect inventory (currently $550K) with ownership activity and broader fundamentals.

Fresh Tracks Therapeutics's inventory is $550K; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.